CCP
Clough Capital Partners Portfolio holdings
AUM
$997M
1-Year Return
37.42%
This Quarter Return
+6.97%
1 Year Return
+37.42%
3 Year Return
+130.83%
5 Year Return
+251.5%
10 Year Return
+1,002%
AUM
$977M
AUM Growth
+$61.2M
(+6.7%)
Cap. Flow
+$25.5M
Cap. Flow
% of AUM
2.61%
Top 10 Holdings %
Top 10 Hldgs %
35.78%
Holding
149
New
31
Increased
28
Reduced
46
Closed
17
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$19.5M |
| 2 |
Dell
DELL
|
$17.4M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$14.9M |
| 4 |
Fidelis Insurance
FIHL
|
$11.4M |
| 5 |
Agilent Technologies
A
|
$10.7M |
Top Sells
| 1 |
Merck
MRK
|
$16M |
| 2 |
Eli Lilly
LLY
|
$15M |
| 3 |
Microsoft
MSFT
|
$14.1M |
| 4 |
UnitedHealth
UNH
|
$11.6M |
| 5 |
Apple
AAPL
|
$10.7M |
Sector Composition
| 1 | Consumer Discretionary | 22.48% |
| 2 | Technology | 20.72% |
| 3 | Healthcare | 12.89% |
| 4 | Industrials | 12% |
| 5 | Communication Services | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Humacyte
HUMA
$230M
| $972K | 0.1% |
+178,768
| New | +$972K |
|
102
Bank of America
BAC
$376B
| $952K | 0.1% |
24,000
| – | – |
|
103
PepsiCo
PEP
$201B
| $942K | 0.1% |
5,540
| – | – |
|
104
Dow Inc
DOW
$16.9B
| $934K | 0.1% |
17,100
| – | – |
|
105
Boston Scientific
BSX
$160B
| $754K | 0.08% |
9,000
| – | – |
|
106
Regeneron Pharmaceuticals
REGN
$60.1B
| $752K | 0.08% |
715
| – | – |
|
107
Costco
COST
$424B
| $748K | 0.08% |
+844
| New | +$748K |
|
108
Oracle
ORCL
$628B
| $699K | 0.07% |
+4,100
| New | +$699K |
|
109
Starwood Property Trust
STWD
$7.45B
| $583K | 0.06% |
28,600
| – | – |
|
|
HQL
110
abrdn Life Sciences Investors
HQL
$406M
| $581K | 0.06% |
38,519
-36,110
| -48% | -$545K |
|
|
HQH
111
abrdn Healthcare Investors
HQH
$897M
| $581K | 0.06% |
31,187
-29,355
| -48% | -$547K |
|
112
VICI Properties
VICI
$35.7B
| $550K | 0.06% |
16,500
| – | – |
|
113
Revvity
RVTY
$9.82B
| $549K | 0.06% |
+4,300
| New | +$549K |
|
114
Illumina
ILMN
$15.3B
| $548K | 0.06% |
+4,200
| New | +$548K |
|
115
Medtronic
MDT
$120B
| $540K | 0.06% |
6,000
-6,900
| -53% | -$621K |
|
116
KLA
KLAC
$115B
| $535K | 0.05% |
691
-545
| -44% | -$422K |
|
117
Gilead Sciences
GILD
$140B
| $528K | 0.05% |
6,300
| – | – |
|
118
argenx
ARGX
$44.9B
| $485K | 0.05% |
895
| – | – |
|
|
RDFN
119
DELISTED
Redfin
RDFN
| $472K | 0.05% |
+37,664
| New | +$472K |
|
120
AT&T
T
$212B
| $447K | 0.05% |
20,300
-32,100
| -61% | -$706K |
|
121
Spotify
SPOT
$144B
| $420K | 0.04% |
+1,140
| New | +$420K |
|
122
Diamondback Energy
FANG
$41.6B
| $415K | 0.04% |
2,409
-45
| -2% | -$7.76K |
|
123
Prudential Financial
PRU
$38.3B
| $400K | 0.04% |
3,300
| – | – |
|
124
BlackRock Health Sciences Trust II
BMEZ
$1.46B
| $380K | 0.04% |
24,000
-24,000
| -50% | -$380K |
|
125
Berkshire Hathaway Class B
BRK.B
$1.09T
| $355K | 0.04% |
771
-20
| -3% | -$9.21K |
|